Doctor Anywhere Funding, Investors & Competitors

Doctor Anywhere has raised $176M across 5 funding rounds, most recently a $41M Series C in December 2023.

Last Doctor Anywhere funding round

$41M

Series C · Dec 2023

Cumulative funding Doctor Anywhere raised

$176M

across 5 funding rounds

Key investors in Doctor Anywhere

  • Novo Holdings
  • Square Peg Capital
  • Kamet Capital Partners
  • EDBI
  • Asia Partners Fund Management
  • IHH Healthcare
  • Pavilion Capital
  • OSK-SBI Venture Partners

Doctor Anywhere Overview

About Doctor Anywhere

Doctor Anywhere is a Singapore-headquartered telehealth provider delivering video consultations, medicine delivery, and chronic care plans across Southeast Asia. The app connects users to GPs in Singapore, Malaysia, and Thailand for 24/7 access. Founded in 2017, it partners with clinics like Fullerton Health.


Founded

2016

HQ

SingaporeSingapore

Status

Privately held

Customer focus

B2C

Revenue model

Services

Doctor Anywhere Funding History

Doctor Anywhere has raised a total of $176M across 5 funding rounds.

Doctor Anywhere's first fundraising round was a $4M Series A in July 2018. The most recent completed round was a $41M Series C in December 2023.

Doctor Anywhere funding rounds

Doctor Anywhere funding rounds
DateStageInvestorsRaisedDeal Summary
Dec 2023Series CNovo Holdings; Square Peg Capital$41MDoctor Anywhere is a Singapore-headquartered tech-led healthcare company providing telehealth, physical clinics, specialist care, and a vertically integrated digital healthcare ecosystem across Southeast Asia. It offers online consultations, prescriptions, end-to-end care management, and has expanded through acquisitions like Asian Healthcare Specialists to address rising demand for comprehensive, patient-centric solutions including secondary care and preventive measures against chronic illnesses. The company focuses on product innovation, regional expansion, and leveraging generative AI for personalized healthcare experiences. On December 6-7, 2023, Doctor Anywhere closed a US$40.8 million (S$54.7 million) Series C1 extension all-equity round with participation from existing investors Square Peg and Novo Holdings, amid a funding winter for startups. This follows prior rounds including a US$38.8 million Series C in December 2022 led by Novo Holdings and a US$27 million Series B in 2020 led by Square Peg. The fresh capital aims to drive next-generation healthcare innovation, deepen secondary care presence, enhance specialties within Asian Healthcare Specialists, and build a connected ecosystem prioritizing patient outcomes. Total funding raised across eight rounds reaches approximately US$176.4 million from 12 investors including EDBI, IHH Healthcare, Pavilion Capital, and Kamet Capital. Traction includes significant growth with 2022 revenue of $51.6 million, up 61.8% from 2021, though losses widened to $44.6 million from $16.3 million. The company has established itself as a regional leader by integrating online and offline care, rapidly acquiring customers, and positioning as the dominant digital health platform in Southeast Asia. Investors like Square Peg highlight its growth trajectory, while Novo Holdings emphasizes commitment to intuitive, outcome-driven care.
Dec 2022Series CNovo Holdings (lead); Asia Partners Fund Management; IHH Healthcare; Square Peg Capital; OSK-SBI Venture Partners; EDBI; Kamet Capital Partners$39MDoctor Anywhere is a Southeast Asia-based healthtech company founded in 2017, initially as a telehealth platform to serve elderly patients at home, and has expanded into virtual and in-person clinics, home visits, chronic disease management, mental wellness, medication delivery, and a health products marketplace. In December 2022, it raised $38.8 million in a Series C1 extension round led by Novo Holdings, with participation from existing investors including Asia Partners, Kamet Capital, Square Peg, IHH Healthcare, EDBI, and OSK-SBI Venture Partners. This 'up round' followed a $65.7 million Series C in August 2021, bringing total funding to nearly $140 million at that time, with proceeds aimed at accelerating growth and partially funding acquisitions. Concurrently with the funding announcement, Doctor Anywhere agreed to acquire Singapore-listed Asian Healthcare Specialists (AHS), a medical services group spanning nine specializations, in a cash deal valued at approximately 109 million SGD (about $76.7 million USD). The acquisition aims to enhance holistic, integrated care by adding secondary specialist services, complementing Doctor Anywhere's primary care offerings and enabling seamless online-offline patient journeys. AHS was to operate independently post-acquisition without major changes, staff layoffs, or asset redeployals. Novo Holdings highlighted Doctor Anywhere's track record as a regional leader in omnichannel healthcare, positioning it to build a broader ecosystem across Southeast Asia. Sources note total funding reaching $176.4 million across multiple rounds by later dates, with a separate $40.8 million Series C-III in December 2023 also led by Novo Holdings.
Aug 2021Series CAsia Partners Fund Management (lead); Novo Holdings$66MDoctor Anywhere is a Singapore-headquartered tech-led healthcare company founded in 2017, offering an omnichannel platform that combines telehealth consultations, in-person clinics, home visits, medication delivery, and an in-app marketplace for health products across Southeast Asia, including Singapore, Malaysia, Thailand, Vietnam, and the Philippines. By August 2021, it served over 1.5 million users, with growth accelerated by COVID-19 driving telehealth adoption. The company recently established tech hubs in Bangalore and Ho Chi Minh City. On August 31, 2021, Doctor Anywhere closed its Series C funding round, raising S$88 million (US$65.7 million), led by Asia Partners with participation from Novo Holdings, Philips, OSK-SBI Venture Partners, and existing investors EDBI, Square Peg, IHH Healthcare, Kamet Capital, and Pavilion Capital. This brought total funding since inception to over S$140 million. Asia Partners co-founder Oliver Rippel and Novo Holdings' Dr. Amit Kakar joined the board. The funds are earmarked for deepening presence in existing markets, expanding to new ones, scaling tech infrastructure and big data for improved online-to-offline experiences, introducing new medical specialty modules, faster medication delivery, and personalized healthcare plans. The round is noted as one of the largest private healthtech financings in Southeast Asia history.
Mar 2020Series BSquare Peg Capital (lead); IHH Healthcare; EDBI; Pavilion Capital; Kamet Capital Partners$27MDoctor Anywhere is a Singapore-based tech-led healthcare company offering a telehealth platform that provides online consultations, prescription management, end-to-end care delivery, and a marketplace for health products and services like supplements and physical therapy. The platform aims to improve healthcare access in Southeast Asia by bridging urban-rural divides, enhancing efficiency for patients, doctors, payors, and care facilities through digital transformation. In March 2020, it closed a US$27 million Series B financing round led by Square Peg Capital, with participation from EDBI, IHH Healthcare, Pavilion Capital, and existing investor Kamet Capital, bringing total funding to over US$40 million at that point. The funds were intended to scale operations, boost market leadership in Asian health-tech, and support regional expansion. This round marked one of the largest financings for a Singapore health-tech startup in under two years, highlighting investor confidence in Doctor Anywhere's model amid high smartphone penetration and a rising middle class in Southeast Asia. Square Peg, investing from its US$230 million 2018 fund, emphasized the company's potential to deliver affordable, high-quality digital care. Co-investors like EDBI (Singapore government arm) and IHH (international healthcare provider) added strategic regional expertise. The investment predated the global pandemic but aligned with growing digital health needs. Post-Series B, Doctor Anywhere continued fundraising, including later Series C extensions totaling around US$40.8 million by late 2023 from Square Peg and Novo Holdings, to drive product innovation, customer acquisition, regional expansion, and acquisitions like Asian Healthcare Specialists. Total funding reached US$176.4 million across multiple rounds by 2023.
Jul 2018Series AKamet Capital Partners (lead)$4MDoctor Anywhere is a Singapore-headquartered telehealth startup founded in 2017 that operates an online platform for patients to book consultations with certified doctors, along with a virtual clinic and marketplace for health products including traditional Chinese medicine and supplements. In July 2018, it raised a Series A round of USD 4.1 million or S$5.6 million led by Kamet Capital Partners to develop products, boost healthcare accessibility in Singapore, expand the team, explore new business verticals, and create more healthcare solutions. Kamet Capital Partners, a Singapore-based family office focusing on early-stage investments in technology and healthcare, participated as the lead investor and provided mentorship. The company later raised a Series B of $27 million in March/April 2020 led by Square Peg Capital with participation from IHH Healthcare, EDBI, Pavilion Capital, and Kamet Capital, bringing its total capital base above $40 million. Subsequent rounds included Series C financings totaling over $100 million by 2022 for regional expansion in Southeast Asia.

Who has invested in Doctor Anywhere?

8 investors have backed Doctor Anywhere across its funding rounds, including Novo Holdings, Square Peg Capital, Kamet Capital Partners, EDBI, Asia Partners Fund Management and IHH Healthcare.

Lead investors include Novo Holdings, Asia Partners Fund Management, Square Peg Capital and Kamet Capital Partners.


Doctor Anywhere Investors

Investors in Doctor Anywhere by funding rounds participated
InvestorHQRoundsRoleFirst check
Novo HoldingsDenmarkCopenhagen3LeadAug 2021
Square Peg CapitalAustraliaSydney3LeadMar 2020
Kamet Capital PartnersSingaporeSingapore3LeadJul 2018
Asia Partners Fund ManagementSingaporeSingapore2LeadAug 2021
IHH HealthcareMalaysiaKuala Lumpur2ParticipantMar 2020
EDBISingaporeSingapore2ParticipantMar 2020

This data is available for Pro users. Sign up to see all 8 Doctor Anywhere investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by Doctor Anywhere

Doctor Anywhere has acquired 2 companies to date.

Last acquisition by Doctor Anywhere was on December 21st 2022. Doctor Anywhere acquired ASIAN Healthcare Specialists for $77M.


Latest Acquisitions by Doctor Anywhere

ASIAN Healthcare Specialists
Doctor Raksa
Description
ASIAN Healthcare Specialists is a Singapore-listed medical group founded in 2013 that delivers specialized services in orthopaedics, dermatology, family medicine, gastroenterology, ophthalmology, and urology. Listed on the Singapore Catalist board, it operates clinics across the island with cross-referral systems for multidisciplinary care. The group treats conditions like spinal injuries, kidney cancer, cataracts, and eczema, serving over 50,000 patients yearly through partnerships with Mount Elizabeth Hospital.
Doctor Raksa is a telemedicine provider leading services in Thailand with expansion into the ASEAN region. Partnerships with hospitals and insurers deliver virtual consultations for general and specialist care via mobile app. Features include video calls, e-prescriptions, and health records access, serving urban and rural populations alike.
HQ CountrySingaporeThailand
HQ City
Singapore
Bangkok
Deal Date21 Dec 202211 Nov 2021
Valuation$77Mundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Doctor Anywhere acquisitions and their M&A valuation multiples.

Start Free Trial

Doctor Anywhere Competitors

Doctor Anywhere competitors include listed companies like Max Healthcare Institute and Oscar Health, and private ones like Devoted Health, Ping An Good Doctor, Ro and WeDoctor.

Public and private companies comparable to Doctor Anywhere
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Devoted HealthUnited StatesBoston, MAPrivate$3.3B-$13B4.0x
Max Healthcare InstituteIndiaIndiaPublicly listed$858M$232M$10B10.2x
Oscar HealthUnited StatesUnited StatesPublicly listed$12B($391M)$9.9B0.4x
Ping An Good DoctorChinaShenzhenPrivate$271M-$8.8B32.5x
RoUnited StatesNew York City, NYPrivate$598M-$7B11.7x
WeDoctorChinaHangzhouPrivate$139M-$7B50.4x

Doctor Anywhere Public Comps

Doctor Anywhere is still privately-owned, but its public comps include Max Healthcare Institute, Oscar Health, Hims, Ping An Healthcare, JMDC, GoodRx, Teladoc, Talkspace, Guiyang Longmaster and Medley Inc..

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Max Healthcare Institute$858M$232M12.6x10.2x46.5x36.8x
Oscar Health$12B($391M)0.5x0.4x(15.9x)12.8x
Hims$2.3B$178M3.1x2.4x40.4x23.9x
Ping An Healthcare$815M$52M0.9x0.9x13.4x16.9x
JMDC$324M$88M5.0x4.6x18.4x17.9x
GoodRx$797M$173M1.8x1.8x8.1x5.5x
Teladoc$2.5B$124M0.6x0.6x11.3x5.0x
Talkspace$229M$6M3.4x3.4x129.3x49.4x

This data is available for Pro users. Sign up to see all Doctor Anywhere competitors and their valuation data.

Start Free Trial

Common questions about Doctor Anywhere

When was Doctor Anywhere founded?Doctor Anywhere was founded in 2016.
Where is Doctor Anywhere headquartered?Doctor Anywhere is headquartered in Singapore, Singapore.
Is Doctor Anywhere publicly listed?No, Doctor Anywhere is a private, VC-backed company.
How much funding has Doctor Anywhere raised?Doctor Anywhere has raised $176M across 5 funding rounds.
What was Doctor Anywhere's last funding round?Doctor Anywhere's last funding round was a $41M Series C in December 2023.
Who are Doctor Anywhere's investors?Doctor Anywhere's investors include Novo Holdings, Square Peg Capital, Kamet Capital Partners, Asia Partners Fund Management, IHH Healthcare, EDBI, OSK-SBI Venture Partners and Pavilion Capital.
Which companies are comparable to Doctor Anywhere?Companies comparable to Doctor Anywhere include Devoted Health, Max Healthcare Institute, Oscar Health, Ping An Good Doctor, Ro and WeDoctor.
How many companies has Doctor Anywhere acquired?Doctor Anywhere has acquired 2 companies, including ASIAN Healthcare Specialists and Doctor Raksa.
What was the largest acquisition by Doctor Anywhere?The $77M acquisition of ASIAN Healthcare Specialists in December 2022 is the largest acquisition Doctor Anywhere has made to date.

See companies similar to Doctor Anywhere

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial